电话:
400-7060-959
传真:
+86 10 56315212-8813
电子邮件:
orders@antibodies-online.cn

Neuregulin 4 抗体 (AA 1-115) (FITC)

NRG4 适用: 人 宿主: 兔 Polyclonal FITC
产品编号 ABIN7164311
发货至: 中国
  • 抗原 See all Neuregulin 4 (NRG4) 抗体
    Neuregulin 4 (NRG4)
    抗原表位
    • 8
    • 6
    • 5
    • 1
    • 1
    AA 1-115
    适用
    • 30
    • 7
    • 3
    • 1
    宿主
    • 29
    • 3
    克隆类型
    • 30
    • 2
    多克隆
    标记
    • 15
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This Neuregulin 4 antibody is conjugated to FITC
    应用范围
    请咨询
    交叉反应
    纯化方法
    >95%, Protein G purified
    免疫原
    Recombinant Human Pro-neuregulin-4, membrane-bound isoform protein (1-115AA)
    亚型
    IgG
    Top Product
    Discover our top product NRG4 Primary Antibody
  • 限制
    仅限研究用
  • 状态
    Liquid
    缓冲液
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    储存液
    ProClin
    注意事项
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    储存条件
    -20 °C,-80 °C
    储存方法
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 抗原
    Neuregulin 4 (NRG4)
    别名
    NRG4 (NRG4 产品)
    别名
    HRG4 antibody, AI552600 antibody, neuregulin 4 antibody, NRG4 antibody, Nrg4 antibody, LOC100347220 antibody
    背景

    Background: Low affinity ligand for the ERBB4 tyrosine kinase receptor. Concomitantly recruits ERBB1 and ERBB2 coreceptors, resulting in ligand-stimulated tyrosine phosphorylation and activation of the ERBB receptors. Does not bind to the ERBB1, ERBB2 and ERBB3 receptors (By similarity).

    Aliases: DKFZp779N0541 antibody, DKFZp779N1944 antibody, Heregulin 4 antibody, HRG4 antibody, Neuregulin 4 antibody, Neuregulin-4 antibody, NRG-4 antibody, NRG4 antibody, NRG4_HUMAN antibody, pro-neuregulin-4, membrane-bound isoform antibody, Pro-NRG4 antibody

    UniProt
    Q8WWG1
    途径
    RTK signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here: